Permanently Discontinued

5% DEXTROSE INJECTION, USP

BAXTER CORPORATION

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is 5% DEXTROSE INJECTION, USP discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that 5% DEXTROSE INJECTION, USP 5G has been permanently discontinued (last updated July 23, 2020). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is 5% DEXTROSE INJECTION, USP not available?

The reason the manufacturer reported: Manufacturing issues.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file2 products

Affected strength5G

Last updated2020-07-23

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

DEXTROSE INJ 50%

INTERNATIONAL MEDICATION SYSTEMS LTD.

500MG · DIN 00243566

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

GLUCOTOL LIQ 75GM/300ML LEMON LIME 75

ATLAS LABS CO LTD.

75G · DIN 00617814

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

⚠ Possible Recall or Safety Alert

Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.

5% DEXTROSE INJECTION, USP

5% DEXTROSE INJECTION, USP: Solution bags may be leaking in affected lots.

Type I2023-10-03

Highest health risk

Possible match — not confirmed

5% Dextrose Injection, USP

5% Dextrose Injection, USP: Solution bags may be leaking in affected lots.

Type I2023-07-20

Highest health risk

Possible match — not confirmed

Dextrose 50 mg/mL Injection USP

Dextrose 50 mg/mL Injection; Out of Specification

Type II2023-05-31

Moderate health risk

Possible match — not confirmed

DIN

00060348

Strength

Dosage Form

SOLUTION

Route

INTRAVENOUS

Active Ingredient

DEXTROSE

See all DEXTROSE products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

2020-07-23

Permanently Discontinued

Manufacturing issues

Other Products from BAXTER CORPORATION

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

(20 MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP

DIN 00438014

(20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP

DIN 00786292

(20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP

DIN 00438049

(20MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP

DIN 00786209

(20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP

DIN 00437999

(40 MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP

DIN 00786217